HYPOXIA
Clinical trials for HYPOXIA explained in plain language.
Never miss a new study
Get alerted when new HYPOXIA trials appear
Sign up with your email to follow new studies for HYPOXIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for Tough-to-Treat kidney cancer
Disease control TerminatedThis study tested a new oral pill called NKT2152 for adults with advanced kidney cancer that had stopped responding to standard treatments. The first part aimed to find a safe and effective dose. The second part planned to see how well the pill could shrink tumors and control the…
Matched conditions: HYPOXIA
Phase: PHASE1, PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New device aims for faster blood test results in surgery
Diagnosis TerminatedThis study tested a new bedside device (Proxima 3®) that quickly measures oxygen, carbon dioxide, and other blood levels in patients during surgery. It compared the device's results to the standard, slower hospital lab equipment. The goal was to see if the new monitor is accurate…
Matched conditions: HYPOXIA
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC